Juan D Cañete Selected Research

Juan D Cañete Research Topics

Disease

57	Rheumatoid Arthritis 05/2022 - 03/2004
35	Psoriatic Arthritis 11/2021 - 05/2004
15	Inflammation (Inflammations) 10/2021 - 07/2008
11	Arthritis (Polyarthritis) 01/2022 - 05/2004
9	Synovitis 01/2022 - 05/2004
7	Infections 01/2020 - 01/2013
6	Palindromic rheumatism 12/2021 - 08/2007
6	Rheumatic Diseases (Rheumatism) 01/2021 - 04/2011
6	Ankylosing Spondylitis 11/2020 - 08/2012
6	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2020 - 01/2016
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 05/2008
4	Pain (Aches) 11/2021 - 07/2014
4	Necrosis 01/2021 - 06/2007
4	Neoplasms (Cancer) 01/2020 - 12/2013
4	Osteoarthritis 03/2016 - 06/2003
3	Fatigue 12/2020 - 07/2016
2	Communicable Diseases (Infectious Diseases) 12/2021 - 01/2020
2	Joint Diseases (Joint Disease) 11/2020 - 01/2016
2	Injection Site Reaction 01/2020 - 06/2015
2	Uveitis 01/2020 - 03/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 01/2016
2	Crohn Disease (Crohn's Disease) 06/2017 - 01/2016
2	Ulcerative Colitis 06/2017 - 01/2016
2	Hyperplasia 09/2011 - 08/2006
1	Fever (Fevers) 12/2021
1	Pericarditis 12/2021
1	Abdominal Pain (Pain, Abdominal) 12/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2020
1	Obesity 06/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Multiple Sclerosis 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Immune System Diseases (Immune Disorders) 01/2020
1	Dysbiosis 01/2020
1	Wounds and Injuries (Trauma) 01/2019
1	type 2C Congenital disorder of glycosylation 01/2019
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2018

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2016 - 03/2004
11	CytokinesIBA 11/2019 - 07/2008
10	Biological ProductsIBA 01/2021 - 01/2005
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2006
9	Tumor Necrosis Factor InhibitorsIBA 01/2019 - 08/2012
8	AutoantibodiesIBA 05/2022 - 06/2007
8	Infliximab (Remicade)FDA Link 01/2016 - 03/2004
7	Etanercept (Enbrel)FDA Link 01/2016 - 03/2004
6	AntibodiesIBA 01/2022 - 01/2009
6	Antirheumatic Agents (DMARD)IBA 01/2021 - 01/2017
6	Peptides (Polypeptides)IBA 01/2020 - 01/2009
5	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2018 - 12/2015
5	Adalimumab (Humira)FDA Link 01/2016 - 08/2012
4	C-Reactive ProteinIBA 01/2022 - 01/2016
4	InterleukinsIBA 01/2020 - 03/2012
4	Interleukin-17 (Interleukin 17)IBA 01/2020 - 07/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2015
3	Rheumatoid FactorIBA 12/2021 - 09/2009
3	ametantrone (HAQ)IBA 11/2021 - 12/2020
3	Immunomodulating AgentsIBA 01/2021 - 01/2016
3	Methotrexate (Mexate)FDA LinkGeneric 07/2018 - 05/2004
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2016 - 12/2015
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2021 - 09/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	tocilizumab (atlizumab)FDA Link 01/2021 - 12/2015
2	EpitopesIBA 01/2017 - 09/2009
2	LigandsIBA 07/2015 - 12/2012
2	DNA (Deoxyribonucleic Acid)IBA 11/2014 - 05/2013
2	acetyl 4-aminosalicylic acidIBA 04/2011 - 05/2008
2	ChemokinesIBA 07/2008 - 06/2007
2	Anti-Citrullinated Protein AntibodiesIBA 05/2008 - 08/2007
1	Janus Kinase InhibitorsIBA 01/2022
1	Colchicine FDA LinkGeneric 12/2021
1	Genetic Markers (Genetic Marker)IBA 10/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	mepolizumabIBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	OvalbuminIBA 01/2021
1	Interleukin-6 InhibitorsIBA 10/2020
1	Prostaglandins AIBA 06/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	CannabinoidsIBA 01/2020
1	ixekizumabIBA 01/2020
1	Butyrates (Butyrate)IBA 01/2020
1	Anti-Idiotypic AntibodiesIBA 01/2020
1	larazotide acetateIBA 01/2020
1	zonulinIBA 01/2020
1	InterferonsIBA 11/2019
1	A-Form DNA (A-DNA)IBA 11/2019
1	Arginine (L-Arginine)FDA Link 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	fos-related antigen 1IBA 01/2019
1	GlycosaminoglycansIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	ArginaseIBA 01/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2018
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 03/2018
1	Leflunomide (Arava)FDA LinkGeneric 03/2018

Therapy/Procedure

22	Therapeutics 01/2022 - 05/2004
11	Biological Therapy 10/2020 - 09/2011